Ob­sE­va makes cuts to lead­er­ship team, board of di­rec­tors in an­oth­er at­tempt to stay afloat

Women’s health biotech Ob­sE­va is down­siz­ing its US-based ex­ec­u­tive team and board of di­rec­tors, the com­pa­ny an­nounced Fri­day, the lat­est in a se­ries of aus­ter­i­ty mea­sures.

Bri­an O’Callaghan stepped down as CEO on Feb. 23. The chief com­mer­cial of­fi­cer, chief clin­i­cal of­fi­cer and chief trans­for­ma­tion of­fi­cer al­so left Ob­sE­va on Thurs­day. The cur­rent CFO, Will Brown, will take on a sec­ond role as in­ter­im CEO while the com­pa­ny search­es for a per­ma­nent leader.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.